Deborah Bilder, MD

Languages Spoken: English, German

Dr. Deborah Bilder is Medical Director of the Neurobehavior HOME Program. In this setting, she provides medical and psychiatric services in a novel medical home program in Salt Lake City, Utah, which serves individuals throughout the lifespan with developmental disabilities. Dr. Bilder also provides psychiatric consultation to the University of Utah’s metabolic genetics clinic for individuals with PKU. She is an Assistant Professor at the University of Utah Department of Psychiatry in the Division of Child and Adolescent Psychiatry. Dr. Bilder received a B.A. degree at Wake Forest University; an M.D degree at Vanderbilt University; and completed her Triple Board (pediatrics, general psychiatry, child and adolescent psychiatry) residency at University of Utah. She is board certified in all three specialties. Following residency, she received certification through pediatrics in Utah Leadership Education in Neurodevelopmental Disabilities. Her research interests include autism epidemiology, autism adult outcomes, and psychiatric complications of PKU.

Deborah Bilder, MD completed the triple board residency program (Pediatrics, General Psychiatry, Child & Adolescent Psychiatry) at the University of Utah and has attained board certified in all three specialties. Following residency, she participated in the Utah Leadership Education in Neurodevelopmental Disabilities (ULEND) as a pediatric trainee. Dr. Bilder is a clinician investigator, Assistant Professor (clinical track), and Medical Director of the Autism Diagnostic Clinic and the Neurobehavior HOME Program. Her two areas of clinical and research expertise are autism spectrum disorders and the management of psychiatric comorbidity associated with phenoketonuria (PKU). Dr. Bilder first began her research career in autism as a CDC-trained expert clinician reviewer for Utah’s autism prevalence study. She has contributed to autism research in the fields of epidemiology, adult outcomes, medical/psychiatric comorbidity, and genetics. Dr. Bilder has co-authored published manuscripts on autism, intellectual disability, and PKU-associated psychiatric disorders. She has assisted with the preparation of successful grant applications in autism adult outcome (Autism Speaks), surveillance (CDC), and genetics (NIH RO1). In regards to PKU, Dr. Bilder has participated in the NIH work group on the long-term cognitive outcomes and follow-up of adults with PKU. She also serves as a consultant to BioMarin Pharmaceutical, Inc.